News + Insights

All
Blog + Whitepapers
Webinars
News
coming-to-america
Secondary Spotlight ‘The most important letters in PE are D-P-I’: Gerald Cooper on the 2024 Secondary...
Read More
Screenshot 2024-04-03 134856
VC Secondary Market Partner Perspectives: Mike Boggs
In this fifth (and final) release in a series of interviews with successful figures in the venture capital...
Read More
New-Product-image
Screenshot 2024-03-26 085921
Hildred Capital Raises $750 Million Continuation Fund
Private-equity firm Hildred Capital Management has closed its first continuation fund to extend its ownership...
Read More
Screenshot 2024-03-22 135127
Nouscom extends Series C round to $82m for cancer vaccine trials
Immuno-oncology company Nouscom has extended a Series C financing round to raise $82m (€75.8m) as it...
Read More
Mission-Therapeutics-raises-25
Mission Therapeutics raises £25.2m to enhance power of mitochondria
Clinical-stage biotech Mission Therapeutics has raised £25.2 million to progress clinical development...
Read More

Flexible capital for the healthcare ecosystem

Disclaimer

The information contained herein is for informational and educational purposes only, does not constitute an offer to sell or the solicitation of an offer to purchase any security, is not presented with a view to providing investment advice with respect to any security, or making any claim as to the past, current or future performance thereof, and Revelation expressly disclaims the use of this information for such purposes. Each recipient should consult its own advisers as to legal, business, tax and other related matters concerning any investment. Statements contained herein are based on current opinions, views and beliefs of Revelation as of the date of the post. Neither Revelation nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein and nothing contained herein should be relied upon as a promise or representation as to past or future performance. Revelation does not have any obligation to update any information included herein. Recipients agree that none of Revelation or its affiliates or its or their respective partners, members, employees, officers, directors, agents, or representatives shall have any liability for any misstatement or omission of fact or any opinion expressed herein.